Prophylactic inhibition of NF-κB expression in microglia leads to attenuation of hypoxic ischemic injury of the immature brain

[1]  Callen T. Wallace,et al.  Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation , 2018, PLoS biology.

[2]  N. Zaghloul,et al.  A model of Periventricular Leukomalacia (PVL) in neonate mice with histopathological and neurodevelopmental outcomes mimicking human PVL in neonates , 2017, PloS one.

[3]  L. Velloso,et al.  Delta cell death in the islet of Langerhans and the progression from normal glucose tolerance to type 2 diabetes in non-human primates (baboon, Papio hamadryas) , 2015, Diabetologia.

[4]  J. Lee,et al.  NF-κB Directly Regulates Fas Transcription to Modulate Fas-mediated Apoptosis and Tumor Suppression* , 2012, The Journal of Biological Chemistry.

[5]  J. Pollard,et al.  Absence of Colony Stimulation Factor-1 Receptor Results in Loss of Microglia, Disrupted Brain Development and Olfactory Deficits , 2011, PloS one.

[6]  H. Kinney,et al.  The Cerebral Cortex Overlying Periventricular Leukomalacia: Analysis of Pyramidal Neurons , 2010, Brain pathology.

[7]  F. Groenendaal,et al.  NF-κB inhibition after neonatal cerebral hypoxia–ischemia improves long-term motor and cognitive outcome in rats , 2010, Neurobiology of Disease.

[8]  John H. Zhang,et al.  Assessing functional outcomes following intracerebral hemorrhage in rats , 2009, Brain Research.

[9]  V. Shestopalov,et al.  Inactivation of astroglial NF‐κB promotes survival of retinal neurons following ischemic injury , 2009, The European journal of neuroscience.

[10]  H. Kinney,et al.  Nitrosative stress and inducible nitric oxide synthase expression in periventricular leukomalacia , 2009, Acta Neuropathologica.

[11]  S. Barnum,et al.  Transgenic Inhibition of Astroglial NF-κB Improves Functional Outcome in Experimental Autoimmune Encephalomyelitis by Suppressing Chronic Central Nervous System Inflammation1 , 2009, The Journal of Immunology.

[12]  J. Volpe,et al.  Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalacia , 2008, Neuropathology and applied neurobiology.

[13]  J. Orange,et al.  Cell penetrating peptide inhibitors of Nuclear Factor-kappa B , 2008, Cellular and Molecular Life Sciences.

[14]  A. Malik,et al.  Ca2+ Influx Induced by Protease-activated Receptor-1 Activates a Feed-forward Mechanism of TRPC1 Expression via Nuclear Factor-κB Activation in Endothelial Cells* , 2006, Journal of Biological Chemistry.

[15]  H. Kinney,et al.  Development of microglia in the cerebral white matter of the human fetus and infant , 2006, The Journal of comparative neurology.

[16]  K. Todd,et al.  Hypoxia‐activated microglial mediators of neuronal survival are differentially regulated by tetracyclines , 2006, Glia.

[17]  M. Mattson,et al.  Roles for NF-κB in nerve cell survival, plasticity, and disease , 2006, Cell Death and Differentiation.

[18]  A. Israël,et al.  NF-κB Regulates Spatial Memory Formation and Synaptic Plasticity through Protein Kinase A/CREB Signaling , 2006, Molecular and Cellular Biology.

[19]  Koji Okabe,et al.  IL-1-induced receptor activator of NF-kappa B ligand in human periodontal ligament cells involves ERK-dependent PGE2 production. , 2005, Bone.

[20]  M. Karjalainen‐Lindsberg,et al.  Nuclear Factor- (cid:1) B Contributes to Infarction After Permanent Focal Ischemia , 2004 .

[21]  B. Aggarwal,et al.  Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues. , 2004, Biochemical pharmacology.

[22]  S. Miyamoto,et al.  Sequential Modification of NEMO/IKKγ by SUMO-1 and Ubiquitin Mediates NF-κB Activation by Genotoxic Stress , 2003, Cell.

[23]  C. Verney,et al.  Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection , 2003, Neuroscience.

[24]  S. Ghosh,et al.  Tumor Necrosis Factor-α Induces Nuclear Factor-κB-dependent TRPC1 Expression in Endothelial Cells* , 2003, Journal of Biological Chemistry.

[25]  H. Kinney,et al.  Nitrosative and Oxidative Injury to Premyelinating Oligodendrocytes in Periventricular Leukomalacia , 2003, Journal of neuropathology and experimental neurology.

[26]  P. Rezaie,et al.  Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system , 2002, Neuropathology : official journal of the Japanese Society of Neuropathology.

[27]  J. Volpe,et al.  Neurobiology of Periventricular Leukomalacia in the Premature Infant , 2001, Pediatric Research.

[28]  D. Ferriero.  Oxidant Mechanisms in Neonatal Hypoxia-Ischemia , 2001, Developmental Neuroscience.

[29]  P. Gressens,et al.  Central Role of Microglia in Neonatal Excitotoxic Lesions of the Murine Periventricular White Matter , 2001, Brain pathology.

[30]  W. Brück,et al.  Association of Increased Bcl‐2 Expression with Rescue from Tumor Necrosis Factor‐α‐Induced Cell Death in the Oligodendrocyte Cell Line OLN‐93 , 2000, Journal of neurochemistry.

[31]  L. Sundstrom,et al.  Attenuation and augmentation of ischaemia‐related neuronal death by tumour necrosis factor‐α in vitro , 2000, The European journal of neuroscience.

[32]  F. Groenendaal,et al.  Effects of Deferoxamine, a Chelator of Free Iron, on Na+,K+-ATPase Activity of Cortical Brain Cell Membrane during Early Reperfusion after Hypoxia-Ischemia in Newborn Lambs , 2000, Pediatric Research.

[33]  Yvonne W Wu,et al.  Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. , 2000, JAMA.

[34]  J. Haas,et al.  Risk factors and determinants of neurodevelopmental outcome in cystic periventricular leucomalacia , 2000, European Journal of Pediatrics.

[35]  A. Fanaroff,et al.  The Relationship Between Placental and Other Perinatal Risk Factors for Neurologic Impairment in Very Low Birth Weight Children , 2000, Pediatric Research.

[36]  P. Gressens,et al.  Intrauterine Infection Induces Programmed Cell Death in Rabbit Periventricular White Matter , 2000, Pediatric Research.

[37]  R. Romero,et al.  Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. , 2000, American journal of obstetrics and gynecology.

[38]  J. Renauld,et al.  Proinflammatory cytokines and interleukin‐9 exacerbate excitotoxic lesions of the newborn murine neopallium , 2000, Annals of neurology.

[39]  A. Leviton,et al.  Labor and delivery characteristics and risks of cranial ultrasonographic abnormalities among very-low-birth-weight infants. The Developmental Epidemiology Network Investigators. , 1999, American journal of obstetrics and gynecology.

[40]  Markus Schwaninger,et al.  NF-κB is activated and promotes cell death in focal cerebral ischemia , 1999, Nature Medicine.

[41]  M. Dragunow,et al.  Neuronal death and survival in two models of hypoxic-ischemic brain damage , 1999, Brain Research Reviews.

[42]  J. Dambrosia,et al.  Interferons and cerebral palsy. , 1999, The Journal of pediatrics.

[43]  B. Popko,et al.  Oligodendroglial Response to the Immune Cytokine Interferon Gamma , 1999, Neurochemical Research.

[44]  N. Bhat,et al.  TNFα potentiates IFNγ‐induced cell death in oligodendrocyte progenitors , 1998 .

[45]  J. Dambrosia,et al.  Neonatal cytokines and coagulation factors in children with cerebral palsy , 1998, Annals of neurology.

[46]  C. Epstein,et al.  Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia , 1998, Annals of neurology.

[47]  Joseph J. Volpe,et al.  Maturation-Dependent Vulnerability of Oligodendrocytes to Oxidative Stress-Induced Death Caused by Glutathione Depletion , 1998, The Journal of Neuroscience.

[48]  C. Albanese,et al.  Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism , 1998 .

[49]  B. Popko,et al.  Developing and mature oligodendrocytes respond differently to the immune cytokine interferon‐gamma , 1998, Journal of neuroscience research.

[50]  O. Dammann,et al.  Increased risk of spastic diplegia among very low birth weight children after preterm labor or prelabor rupture of membranes. , 1998, The Journal of pediatrics.

[51]  F. Faraci,et al.  Tumor Necrosis Factor-α–Induced Dilatation of Cerebral Arterioles , 1998 .

[52]  R. Frydman,et al.  Are neonatal brain lesions due to intrauterine infection related to mode of delivery? , 1998, British journal of obstetrics and gynaecology.

[53]  J. Chi,et al.  Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. , 1997, American journal of obstetrics and gynecology.

[54]  K. Nelson,et al.  Maternal infection and cerebral palsy in infants of normal birth weight. , 1997, JAMA.

[55]  R. Romero,et al.  Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy , 1997 .

[56]  M. Dehan,et al.  PERIVENTRICULAR LEUKOMALACIA: RISK FACTORS REVISITED , 1996, Developmental medicine and child neurology.

[57]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[58]  V. Saletti,et al.  MRI features of cerebral lesions and cognitive functions in preterm spastic diplegic children. , 1996, Pediatric neurology.

[59]  B. Juurlink,et al.  Low Glutathione and High Iron Govern the Susceptibility of Oligodendroglial Precursors to Oxidative Stress , 1996, Journal of neurochemistry.

[60]  J. Perlman,et al.  Bilateral cystic periventricular leukomalacia in the premature infant: associated risk factors. , 1996, Pediatrics.

[61]  G. Levi,et al.  Reversible Inhibitory Effects of Interferon‐γ and Tumour Necrosis Factor‐α on Oligodendroglial Lineage Cell Proliferation and Differentiation In Vitro , 1996 .

[62]  R. Romero,et al.  Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. , 1996, American journal of obstetrics and gynecology.

[63]  K. Nelson,et al.  Prenatal and perinatal factors and cerebral palsy in very low birth weight infants. , 1996, The Journal of pediatrics.

[64]  Meijuan Zhao,et al.  Interferon-γ-Induced Oligodendrocyte Cell Death: Implications for the Pathogenesis of Multiple Sclerosis , 1995, Molecular medicine.

[65]  K. Hossmann,et al.  Reactive microglia in cerebral ischaemia: an early mediator of tissue damage? , 1995, Neuropathology and applied neurobiology.

[66]  M. Noble,et al.  N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[67]  L. Ignarro,et al.  Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. , 1993, Journal of immunology.

[68]  J. Louis,et al.  CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death , 1993, Science.

[69]  C. Brosnan,et al.  Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. , 1991, Journal of immunology.

[70]  M. Mattson,et al.  Roles for NF-kappaB in nerve cell survival, plasticity, and disease. , 2006, Cell death and differentiation.

[71]  S. Miyamoto,et al.  Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. , 2003, Cell.

[72]  S. Ghosh,et al.  Tumor necrosis factor-alpha induces nuclear factor-kappaB-dependent TRPC1 expression in endothelial cells. , 2003, The Journal of biological chemistry.

[73]  G. Buonocore,et al.  Early neonatal brain injury in histologic chorioamnionitis. , 2001, The Journal of pediatrics.

[74]  E. Melhem,et al.  Periventricular leukomalacia: relationship between lateral ventricular volume on brain MR images and severity of cognitive and motor impairment. , 2000, Radiology.

[75]  R. Romero,et al.  Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. , 1997, American journal of obstetrics and gynecology.

[76]  G. Levi,et al.  Reversible inhibitory effects of interferon-gamma and tumour necrosis factor-alpha on oligodendroglial lineage cell proliferation and differentiation in vitro. , 1996, The European journal of neuroscience.

[77]  D. Baltimore,et al.  NF-kappa B: ten years after. , 1996, Cell.

[78]  H. Hattori,et al.  Inhibitor of Nitric Oxide Synthesis Reduces Hypoxic-Ischemic Brain Damage in the Neonatal Rat , 1994, Pediatric Research.